Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2471028019 | Proteasome inhibitor | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3520808016 | Substance with proteasome inhibitor mechanism of action (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3559304018 | Substance with proteasome inhibitor mechanism of action | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3166471000052116 | proteasomhämmare | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Proteasome inhibitor | Is a | Antineoplastic agent (substance) | true | Inferred relationship | Some | ||
| Proteasome inhibitor | Is a | Immunomodulator | true | Inferred relationship | Some | ||
| Proteasome inhibitor | Has disposition (attribute) | Proteasome inhibitor (disposition) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Bortezomib (substance) | Is a | True | Proteasome inhibitor | Inferred relationship | Some | |
| Carfilzomib | Is a | True | Proteasome inhibitor | Inferred relationship | Some | |
| Ixazomib (substance) | Is a | True | Proteasome inhibitor | Inferred relationship | Some | |
| Product containing proteasome inhibitor (product) | Has active ingredient | True | Proteasome inhibitor | Inferred relationship | Some | 1 |
| Ixazomib citrate | Is a | True | Proteasome inhibitor | Inferred relationship | Some |
This concept is not in any reference sets
FHIR